Insider · CIK 0001856682

Vellanki Avanish

Reports to the SEC for 1 company · NEWARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001856682

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-01-26	Rain Oncology Inc.U Disposition from Tender	Director, Chairman and CEO	UDisposition from Tender	−2.55M sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−14.1K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−31.8K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−30.2K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−304K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−267K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−133K sh	—	—	0
2024-01-26	Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chairman and CEO	DDisposition to Issuer	−152K sh	—	—	0
2023-08-09	Rain Oncology Inc.Stock Option (Right to Buy)A Award	Director, Chairman and CEO	AAward	+267K sh	—	—	266,500
2023-08-09	Rain Oncology Inc.Stock Option (Right to Buy)A Award	Director, Chairman and CEO	AAward	+133K sh	—	—	133,250
2023-02-15	Rain Oncology Inc.Stock Option (Right to Buy)A Award	Director, Chairman and CEO	AAward	+319K sh	—	—	318,600
2022-06-01	Rain Oncology Inc.P Purchase	Director, Chairman and CEO	PPurchase	+25K sh	$2.29	+$57.3K	2,471,627
2022-04-14	Rain Oncology Inc.G Gift	Director, Chairman and CEO	GGift	−59.6K sh	—	—	79,283
2022-04-14	Rain Oncology Inc.G Gift	Director, Chairman and CEO	GGift	+59.6K sh	—	—	2,446,627
2022-03-11	Rain Oncology Inc.M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+14.5K sh	$4.00	+$57.9K	2,837,009
2022-03-11	Rain Oncology Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−14.5K sh	—	—	31,832
2022-02-02	Rain Oncology Inc.Stock Option (Right to Buy)A Award	Director, Chairman and CEO	AAward	+182K sh	—	—	182,300
2021-04-27	Rain Oncology Inc.C Conversion	Director, Chairman and CEO	CConversion	+11.2K sh	—	—	2,372,541
2021-04-27	Rain Oncology Inc.Series A Preferred StockC Conversion	Director, Chairman and CEO	CConversion	−12.1K sh	—	—	0

Recent filings

Accepted (ET)
Jan 264
Vellanki Avanish0001999371-24-000956
SEC(opens sec.gov)
Aug 114
Vellanki Avanish0001104659-23-090706
SEC(opens sec.gov)
Feb 174
Vellanki Avanish0001104659-23-023386
SEC(opens sec.gov)
Jun 24
Vellanki Avanish0000899243-22-020666
SEC(opens sec.gov)
Apr 154
Vellanki Avanish0000899243-22-014885
SEC(opens sec.gov)
Mar 154
Vellanki Avanish0000899243-22-011033
SEC(opens sec.gov)
Feb 44
Vellanki Avanish0000899243-22-004830
SEC(opens sec.gov)
Apr 274
Vellanki Avanish0000899243-21-017111
SEC(opens sec.gov)

Companies

Rain Oncology Inc.Director, Chairman and CEO

Address

C/O RAIN THERAPEUTICS INC. 8000 JARVIS AVENUE, SUITE 204

NEWARK, CA, 94560